Piramal Critical Care unveils new 10mg/10mL (1 mg/mL) concentration of Zinc Sulfate for Injection in US
Bethlehem: Piramal Critical Care (PCC), a division of Piramal Pharma Limited, has announced the launch of a new 10mg/10mL (1 mg/mL) concentration of Zinc Sulfate for Injection USP in the U.S.
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio. Zinc Sulfate is a trace element indicated in adult and pediatric patients as a source of zinc for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. This intravenous nutritional injection is available in three strengths: 30mg/10mL (3mg/mL), 25mg/5mL (5mg/mL), and the new 10mg/10mL (1mg/mL) concentration. The 1 mg/mL concentration is recommended for use in pediatric patients, particularly those weighing less than 26 pounds.
Read also: Piramal Pharma Solutions unveils in-vitro biology capabilities at Ahmedabad Discovery Services Site
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.